Medical Advisor | Senior Medical Advisor - Neuroscience at Eli Lilly and Company

Basingstoke, England, United Kingdom

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Full registered GMC or eligible Physician/Pharmacist and basic medical/pharmacy qualification (e.g. MBBS/MD)
Desired therapeutic expertise in the clinical and/or industry within Neurodegeneration
Working experience as an ABPI Final Signatory
Demonstrated ability to plan, organize, prioritise and adapt to changing priorities

Responsibilities

Provide medical expertise in Neuroscience across the Lilly Neurodegeneration product portfolio, including affiliate, regional and global teams, contributing to medical strategies and brand commercialization
Ensure detailed, current knowledge of the respective Molecule(s) data and contribute scientific and medical expertise to develop effective partnerships with relevant functions (e.g. PRA, Clinical Operations, Corporate Affairs, Human Resources, Legal, Marketing, Medical Information, Global Product Safety, and Training)
Knowledge of compliance with local laws and regulations, global policies and procedures, and compliance guidelines regarding data dissemination and interactions with external healthcare professionals
Review and approve promotional and non-promotional materials in line with local compliance guidelines
Drive the response to challenges from competitors, the PMCPA, and the MHRA within predetermined timelines
Provide visible leadership to other members of the Medical Department and the broader UK business
Understand and anticipate the information needs of all payers, patients, and health care providers, particularly giving clinical input and insight to develop payer partnership programs
Contribute to Medical Education activities, including business planning, approval and certification of materials, and scientific data exchange/dissemination
Assist Medical Information and Global Product Safety UK as requested, including out-of-hours calls
Provide initial and ongoing disease, product, and competitor training for all Lilly employees and HCPs, as determined by business needs
Support the planning of symposia, advisory boards, and medical meetings, preparation, and review of medical letters and other medical information assets

Skills

Neuroscience

Neurodegeneration

Medical Affairs

Strategic Planning

Commercialization

Medical Expertise

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free